Guru Fundamental Report for TMO

According to Validea's guru fundamental report, Thermo Fisher Scientific (TMO) receives a 62% rating based on its Low PE Investor model, which is based on the investment strategy of John Neff. The analysis indicates that TMO, a large-cap growth stock, passes criteria for EPS growth, future EPS growth, sales growth, EPS persistence, and free cash flow, but fails tests for P/E ratio and total return/PE. The Neff strategy seeks firms with persistent earnings growth trading at a discount, and a score of 80% or higher typically indicates interest in the stock.

Analysis

Thermo Fisher Scientific Inc. (TMO), a large-cap growth stock within the Medical Equipment & Supplies industry, receives a 62% rating from Validea's Low PE Investor model, based on John Neff's strategy. This score is below the 80% threshold that typically indicates strategy interest. The Neff model prioritizes firms with persistent earnings growth trading at a discount relative to their earnings growth and dividend yield. TMO demonstrates strength in several fundamental areas, passing criteria for EPS growth, future EPS growth, sales growth, free cash flow, and EPS persistence. However, it fails on valuation-sensitive metrics, specifically P/E ratio and total return/PE. This suggests that while TMO exhibits robust operational performance and growth characteristics, its current market valuation does not align with the discount criteria sought by the Neff strategy.

Key Decisions for Investors

• Investors should note TMO's strong underlying fundamentals, including positive EPS growth, sales growth, and free cash flow, which are attractive attributes for growth-focused portfolios.
• The failing grades on P/E ratio and total return/PE according to the Neff model indicate potential valuation concerns, suggesting the stock may not be undervalued by these specific metrics.
• Consider TMO's growth prospects against its current valuation; those strictly adhering to value strategies like Neff's might find it less appealing, while others might weigh the growth indicators more heavily.